Human TNFAIP3 Ready-To-Use IHC Kit target-protein_EphB2 R A chromosomal translocation involving this

A chromosomal translocation involving this gene and the IgH locus

CAD17_HUMAN

Conjugation None Clone# Bavituximab Formulation 100 mM Pro-Ac 20mM Arg pH 5

MMP9 (matrix metallopeptidase 9

: IHC0330R

Human TNFAIP3 Ready-To-Use IHC Kit target-protein_EphB2 R A chromosomal translocation involving thisHuman TNFAIP3 Ready To Use IHC Kit Cat. No.: IHC0469H Sample Type: FFPE tissue Size: 50T (including a control slide) Storage and Stability: Please store components at the temperatures indicated on the individual tube labels. The kit is stable for 6 months from the date of receipt. Background TNFAIP3, also known as A20, is located in chromosome band 6q23, a region that is often deleted in B cell lymphomas. Recently, it was identified as a tumor